Impact of Quality by Design Development on the Review Period of New Drug Approval and Product Quality in Japan

被引:0
|
作者
Eiji Kajiwara
Haruki Kamizato
Mayumi Shikano
机构
[1] Kitanomaru Square,MSD K.K
[2] Tokyo University of Science,Department of Pharmaceutical Sciences
来源
Therapeutic Innovation & Regulatory Science | 2020年 / 54卷
关键词
Recall; Quality by design (QbD); Review period; Real time release testing (RTRT); Design space;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1192 / 1198
页数:6
相关论文
共 50 条
  • [1] Impact of Quality by Design Development on the Review Period of New Drug Approval and Product Quality in Japan
    Kajiwara, Eiji
    Kamizato, Haruki
    Shikano, Mayumi
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2020, 54 (05) : 1192 - 1198
  • [2] A New Roadmap for Biopharmaceutical Drug Product Development: Integrating Development, Validation, and Quality by Design
    Martin-Moe, Sheryl
    Lim, Fredric J.
    Wong, Rita L.
    Sreedhara, Alavattam
    Sundaram, Jagannathan
    Sane, Samir U.
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2011, 100 (08) : 3031 - 3043
  • [3] The application of Quality by Design principles in drug product development
    Stott, P.
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2007, 59 : A73 - A73
  • [4] Quality by Design in Pharmaceuticals: A Review of its Impact on Regulatory Compliance and Product Quality
    Nunavath, Raja Shekhar
    Singh, Madhu Tanya
    Jain, Anubha
    Chakma, Marjita
    Arivuselvam, Rajaguru
    Azeeze, Mohamed Sheik Tharik Abdul
    DRUG RESEARCH, 2024, 74 (01) : 18 - 23
  • [5] Product approval by quality categories
    Simonov, Yu.
    Standarty i Kachestvo, 2005, (10):
  • [6] New product quality and product development teams
    Sethi, R
    JOURNAL OF MARKETING, 2000, 64 (02) : 1 - 14
  • [7] New drug approval process in Japan
    Hayakawa, T
    CURRENT OPINION IN BIOTECHNOLOGY, 1999, 10 (03) : 307 - 311
  • [8] New product development: Speed and quality
    Wadhwani, DH
    Schroeder, RG
    DECISION SCIENCES INSTITUTE, 1997 ANNUAL MEETING, PROCEEDINGS, VOLS 1-3, 1997, : 1370 - 1372
  • [9] PAT: A new dawn for drug product quality
    Drakulich, Angie
    Van Arnum, Patricia
    Pharmaceutical Technology, 2010, 34 (02) : 38 - 45
  • [10] Reconciling Quality by Design and Transdermal Product Development
    Miller, Kenneth, II
    PHARMACEUTICS, 2020, 12 (03)